Medical treatment in acute and long-term secondary prevention after transient ischaemic attach and ischaemic stroke

Journal article

Abstract:: Stroke is a major cause of death and disability worldwide. Without improvements in prevention, the burden will increase during the next 20 years because of the ageing population, especially in developing countries. Major advances have occurred in secondary prevention during the past three decades, which demonstrate the broader potential to prevent stroke. We review the main medical treatments that should be considered for most patients with transient ischaemic attach or ischaemic stroke in the acute phase and the long term, and draw attention to recent developments.

Institution:: Rudolf Magnus Institute of Neuroscience and Julius Center for General Health Sciences and Primary Care, University Medical Center, Utrecht, Netherlands
Department:: Department of Neurology
Role:: Author

Institution:: Paris 7 Denis Diderot University, Unité INSERM 698: Recherche Clinique en Athérothrombose, Groupe Hospitalier Bichat Claude Bernard, Paris, France
Department:: Neurology and Stroke Deparments
Role:: Author

Language:: English
Keywords:: acute secondary prevention

long-term secondary prevention

lipid modification

antihypertensive drugs

stroke

antithrombotic treatment
Subjects:: Neuroscience

Medical sciences

Stroke
UUID:: uuid:77e50907-a624-459b-a166-103327e418fa
Local pid:: ora:5505
Deposit date:: 2011-06-27

Copyright holder:: Elsevier
Notes:: The full-text of this article is not available in ORA, but you may be able to access the article via the publisher copy link on this record page.

Licence:: Terms and Conditions of Use for Oxford University Research Archive

If you are the owner of this record, you can report an update to it here: Report update to this record